February 4, 2020
Burlington, Ontario – February , 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation“) is pleased to announce the company has secured government funding of $400,000 from The National Research Council of Canada Industrial Research Assistance (NRC-IRAP), to support a project focused...
January 23, 2020
Burlington, Ontario – January , 2020 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation“) is pleased to announce their newest research partnership program entitled “Rapid Delivery of Therapeutics via Dissolution of Polymeric Films” with McMaster University, located in Hamilton, Ontario, Canada. This...
December 6, 2019
Burlington, Ontario – December , 2019 – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Corporation”) is pleased to announce that all of the nominees listed in the Corporation’s management information circular dated November 11, 2019 were elected as directors of the Corporation at...
November 19, 2019
BURLINGTON, Ontario – November 19, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Corporation”) (CSE: DOSE) today reported that is has been issued a micro-processing licence by Health Canada for its Burlington, Ontario facility in accordance with the Cannabis Act and Cannabis Regulations. “This...
October 30, 2019
BURLINGTON, Ontario – October 30, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Corporation”) (CSE: DOSE) today reported its financial results for the second quarter of fiscal 2020, which ended on August 31, 2019. “We are very pleased to announce the recognition of revenue...
October 9, 2019
BURLINGTON, Ontario, October 9, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Corporation”) (CSE: DOSE) is pleased to announce that today it has completed the first closing of a private placement of common shares in the capital of the Corporation (“Common Shares”) at a...
September 12, 2019
Burlington, ON, September 12, 2019 — Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) announced today that the results of a research study conducted by the University of Nevada, Las Vegas (“UNLV”) was published in the high impact journal, Frontiers in Pharmacology, on September 10, 2019....
September 10, 2019
Burlington, Ontario – September 10, 2019 – Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) announced today that the installation and commissioning of its QuickStrip™ production equipment at Aphria Inc. (“Aphria”) (TSX: APHA and NYSE: APHA) has been completed pursuant to the terms of the Managed...
September 4, 2019
Burlington, Ontario – September 4, 2019 – Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) announced today that the installation of its QuickStrip™production equipment at Chemesis International Inc. (“Chemesis”) (CSE: CSI) (OTC: CADMF) (FRA: CWAA) is now complete, enabling the immediate recognition of revenue to RDT...
August 20, 2019
Burlington, ON, August 20, 2019 — Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) announced today the commencement of a clinical research trial with the GI Research Institute (“GIRI”) and the University of British Columbia (“UBC”) under the direction of Dr. Brian L. Bressler, MD, as...